Practical Evaluation of Immunotherapy in MASH-Associated HCC – Case Studies
We are pleased to announce an upcoming webinar focused on the evaluation of immunotherapy in hepatocellular carcinoma (HCC) arising from metabolic dysfunction–associated steatohepatitis (MASH).
In this webinar, we will introduce practical case studies using the STAM-IO model, a preclinical in vivo platform that recapitulates key pathological features of MASH-associated HCC. The session will highlight study design approaches for immune checkpoint inhibitor (ICI) monotherapy and combination therapies, along with key readouts such as tumor growth, immune cell infiltration, and fibrosis.
This webinar is recommended for researchers and drug developers working in immuno-oncology and MASH-HCC research.
https://www.linkedin.com/events/7423871554796756992/?viewAsMember=true